Kewaunee Scientific (KEQU)
(Delayed Data from NSDQ)
$53.85 USD
+0.50 (0.94%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $53.09 -0.76 (-1.41%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KEQU 53.85 +0.50(0.94%)
Will KEQU be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KEQU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KEQU
Top Research Reports for NVIDIA, Palantir & Coca-Cola
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
KEQU: What are Zacks experts saying now?
Zacks Private Portfolio Services
KEQU Reports Y/Y Earnings Decline in Q3 Despite Strong Sales Growth
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
Other News for KEQU
Insider Sell: Gardner Donald T. III Sells 3,000 Shares of Kewaunee Scientific Corp (KEQU)
Kewaunee Scientific: Huge Improvement In Operational Outlook (Upgrade To Buy)
12 Health Care Stocks Moving In Thursday's Intraday Session
Kewaunee Scientific Reports Strong Fiscal Year 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session